CARB-X adds new members to increase number of funded antimicrobial research projects

Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) added six new organizations to its coalition, bringing its total membership to 10.

With the new members, the non-profit aims to increase the number of early development antibacterial research projects it financially supports to 60 from 34. Its portfolio includes projects developing new classes of antibiotics against Gram-negative bacteria...